Abstract
Toxicogenomics is a rapidly developing discipline focused on the elucidation of the molecular and cellular effects of chemicals on biological systems. As a collaborative study group of Toxicogenomics/JEMS·MMS, we conducted studies on hepatocarcinogens in rodent liver in which 100 candidate marker genes were selected to discriminate genotoxic hepatocarcinogens from non-genotoxic hepatocarcinogens. Differential gene expression induced by 13 chemicals were examined using DNA microarray and quantitative real-time PCR (qPCR), including eight genotoxic hepatocarcinogens [o-aminoazotoluene, chrysene, dibenzo[a,l]pyrene, diethylnitrosamine (DEN), 7,12-dimethylbenz[a]anthracene, dimethylnitrosamine, dipropylnitrosamine and ethylnitrosourea (ENU)], four non-genotoxic hepatocarcinogens [carbon tetrachloride, di(2-ethylhexyl)phthalate (DEHP), phenobarbital and trichloroethylene] and a non-genotoxic non-hepatocarcinogen [ethanol]. Using qPCR, 30 key genes were extracted from mouse livers at 4 h and 28 days following dose-dependent gene expression alteration induced by DEN and ENU: the most significant changes in gene expression were observed at 4 h. Next, we selected key point times at 4 and 48 h from changes in time-dependent gene expression during the acute phase following administration of chrysene by qPCR. We successfully showed discrimination of eight genotoxic hepatocarcinogens [2-acetylaminofluorene, 2,4-diaminotoluene, diisopropanolnitrosamine, 4-dimethylaminoazobenzene, 4-(methylnitsosamino)-1-(3-pyridyl)-1-butanone, N-nitrosomorpholine, quinoline and urethane] from four non-genotoxic hepatocarcinogens [1,4-dichlorobenzene, dichlorodiphenyltrichloroethane, DEHP and furan] using qPCR and principal component analysis. Additionally, we successfully identified two rat genotoxic hepatocarcinogens [DEN and 2,6-dinitrotoluene] from a nongenotoxic-hepatocarcinogen [DEHP] and a non-genotoxic non-hepatocarcinogen [phenacetin] at 4 and 48 h. The subsequent gene pathway analysis by Ingenuity Pathway Analysis extracted the DNA damage response, resulting from the signal transduction of a p53-class mediator leading to the induction of apoptosis. The present review of these studies suggests that application of principal component analysis on the gene expression profile in rodent liver during the acute phase is useful to predict genotoxic hepatocarcinogens in comparison to non-genotoxic hepatocarcinogens and/or non-carcinogenic hepatotoxins.
Highlights
A radical overhaul of toxicological test protocols has been proposed [1,2,3,4]
We successfully showed the discrimination of genotoxic and non-genotoxic hepatocarcinogens in mouse liver [12] and rat liver [13] by quantitative real-time PCR (qPCR) and the application of principal component analysis (PCA) at 4 and 48 h after administration of hepatocarcinogens
We selected and quantified by qPCR candidate marker genes to discriminate mouse genotoxic hepatocarcinogens from non-genotoxic hepatocarcinogens examined by DNA microarrays
Summary
A radical overhaul of toxicological test protocols has been proposed [1,2,3,4]. We reported the results from 35 genes: 34 genes [Aen, Bax, Bhlhe, Btg, Ccnf, Ccng, Cdkn1a, Cyp1a2, Ddit, Ddit4l, Egfr, Ephx, Gadd45b, Gdf, HistH1, Hmox, Hspb, Igfbp, Jun, Lrp, Ly6a, Mbd, Mdm, Phlda, Plk, Pml, Pmm, Ppp1r3c, Psma, Rad, Rcan, St3gal, Trp, and Tubb4b (Tubb2c)] showed statistically significant changes in their gene expression, at least once at 4 h and/or 48 h, as computed by the Dunnett’s test using the Gapdh gene to normalize the data. We reported results from 33 genes: 32 genes [Aen, Bax, Btg, Ccnf, Ccng, Cdkn1a, Cyp21a1, Cyp4a1, Ddit4l, Egfr, Ephx, Gadd45b, Gadd45g, Gdf, Hhex, Hmox, Hspb, Igfbp, Jun, Lpp, Ly6al, Mdm, Myc, Net, Phlda, Plk, Pml, Pmm, Rcan, Tnf, Tp53, and Tubb4b (Tubb2c)] exhibited statistically significant changes in expression according to statistical analysis using the Williams’ test and the Dunnett’s test; and a normalized gene, Gapdh. This study showed that mouse candidate marker genes are applicable to rats for the differentiation of the genotoxic hepatocarcinogens from the non-genotoxic hepatocarcinogens examined in this study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.